Solarfun Launches New ECLIPSE Series of PV Cells/Modules Featuring Reduced LID

Solarfun Power Holdings Co., Ltd. ("Solarfun" or "the Company") (Nasdaq: SOLF), a vertically integrated manufacturer of silicon ingots and photovoltaic "PV" cells and modules in China, today announced the introduction of "ECLIPSE," a new line of PV cells and modules with reduced light induced degradation (LID).

The largest percentage of degradation of PV modules occurs during the first day of sun exposure.  "ECLIPSE" reduces the impurity concentration in cells, therefore reducing the relative LID to about 1% from 2% to 3%, or less than 2W compared to about 4W to 5W for a 180W module equipped with standard cells.

This results in an increase in electricity generation of about 1% to 2% more power over a one-, five-, 10-, and 25- year period when compared with standard modules.

Peter Xie, President of Solarfun, commented, "We have devoted considerable resources and management attention to develop and produce differentiated products. We are proud to introduce this innovation in our new 'ECLIPSE' line with reduced LID.   The advance is made possible by our vertically integrated manufacturing model and ability to control the quality of raw materials throughout the production process.  By adjusting chemical properties in both the ingot-making and cell-processing phases of manufacturing, we have achieved a low concentration of impurity while still maintaining high yields.  We remain committed to our strategy of continually enhancing our technology to produce differentiated and more efficient products for our customers."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.